Personal information

Verified email addresses

Belgium

Activities

Employment (5)

Janssen (Belgium): Beerse, BE

2022-02-01 to present | Associate Director (Clinical Pharmacology and Pharmacometrics)
Employment
Source: Self-asserted source
Ruben Faelens

Katholieke Universiteit Leuven: Leuven, BE

2018-09-03 to 2022-09-07 | PhD researcher
Employment
Source: Self-asserted source
Ruben Faelens

SGS Exprimo: Leuven, BE

2014-03-01 to 2018-08-01 | IT Scientist
Employment
Source: Self-asserted source
Ruben Faelens

ONE Agency / AUSY NV: Leuven, BE

2013-09 to 2014-03 | Technical Sales
Employment
Source: Self-asserted source
Ruben Faelens

Altran SA/NV: Brussels, BE

2010-09 to 2013-09 | Advanced Consultant (Software Development)
Employment
Source: Self-asserted source
Ruben Faelens

Education and qualifications (2)

Katholieke Universiteit Leuven Faculteit Farmaceutische Wetenschappen: Leuven, Flanders, BE

2017-10-01 to 2022-09-07 | PhD (Drug Delivery and Disposition)
Education
Source: Self-asserted source
Ruben Faelens

Katholieke Universiteit Leuven Faculteit Ingenieurswetenschappen: Leuven, Vlaams-Brabant, BE

2008-09-01 to 2010-07-01 | Master of Science -- Computer Sciences, distributed systems
Education
Source: Self-asserted source
Ruben Faelens

Works (11)

Model-Informed Clinical Development of Once-Every-6-Month Injection of Paliperidone Palmitate in Patients with Schizophrenia: A Pharmacometric Bridging Approach (Part I)

European Journal of Drug Metabolism and Pharmacokinetics
2024-05-15 | Journal article
Part of ISSN: 2107-0180
Contributors: Huybrecht T'jollyn; Alberto Russu; Raja Venkatasubramanian; Srihari Gopal; Partha Nandy; Martine Neyens; Ruben Faelens; Mahesh N. Samtani; Oliver Ackaert; Juan Jose Perez-Ruixo
Source: Self-asserted source
Ruben Faelens via Crossref Metadata Search

Erdafitinib’s effect on serum phosphate justifies its pharmacodynamically guided dosing in patients with cancer

CPT: Pharmacometrics & Systems Pharmacology
2022-05 | Journal article
Contributors: Anne‐Gaëlle Dosne; Elodie Valade; Kim Stuyckens; Peter De Porre; Anjali Avadhani; Anne O’Hagan; Lilian Y. Li; Daniele Ouellet; Ruben Faelens; Quentin Leirens et al.
Source: check_circle
Crossref

Predicting model‐informed precision dosing: A test‐case in tacrolimus dose adaptation for kidney transplant recipients

CPT: Pharmacometrics & Systems Pharmacology
2022-02-02 | Journal article
Part of ISSN: 2163-8306
Contributors: Ruben Faelens; Nicolas Luyckx; Dirk Kuypers; Thomas Bouillon; Pieter Annaert
Source: Self-asserted source
Ruben Faelens via Crossref Metadata Search

Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis

Pharmaceutics
2021-10-06 | Journal article
Contributors: Ruben Faelens; Zhigang Wang; Thomas Bouillon; Paul Declerck; Marc Ferrante; Séverine Vermeire; Erwin Dreesen
Source: check_circle
Crossref

Spatiotemporal imaging and pharmacokinetics of fluorescent compounds in zebrafish eleuthero-embryos after different routes of administration

Scientific Reports
2021-06-09 | Journal article
Part of ISSN: 2045-2322
Contributors: Marlly Guarin; Ruben Faelens; Arianna Giusti; Noémie De Croze; Marc Léonard; Deirdre Cabooter; Pieter Annaert; Peter de Witte; Annelii Ny
Source: Self-asserted source
Ruben Faelens via Crossref Metadata Search

Glomerular Filtration Rate in Asphyxiated Neonates Under Therapeutic Whole-Body Hypothermia, Quantified by Mannitol Clearance

Clinical Pharmacokinetics
2021-02-21 | Journal article
Part of ISSN: 1179-1926
Contributors: Neel Deferm; Kim V. Annink; Ruben Faelens; Michael Schroth; Christian A. Maiwald; Loubna el Bakkali; Frank van Bel; Manon J. N. L. Benders; Mirjam M. van Weissenbruch; Anja Hagen et al.
Source: Self-asserted source
Ruben Faelens via Crossref Metadata Search

Optimising infliximab induction dosing for patients with ulcerative colitis

British Journal of Clinical Pharmacology
2019-02-10 | Journal article
Part of ISSN: 0306-5251
Contributors: Erwin Dreesen; Ruben Faelens; Gert Van Assche; Marc Ferrante; Séverine Vermeire; Ann Gils; Thomas Bouillon
Source: Self-asserted source
Ruben Faelens via Crossref Metadata Search

Mo1846 - Adaptive Dosing During Infliximab Induction Therapy can Improve Mucosal Healing Rates in Patients with Ulcerative Colitis

Gastroenterology
2018-05 | Journal article
Part of ISSN: 0016-5085
Contributors: Erwin Dreesen; Ruben Faelens; Gert A. Van Assche; Marc Ferrante; Severine Vermeire; Ann Gils; Thomas Bouillon
Source: Self-asserted source
Ruben Faelens via Crossref Metadata Search

P642 Adaptive dosing during infliximab induction therapy can improve mucosal healing rates in patients with ulcerative colitis

Journal of Crohn's and Colitis
2018-01 | Journal article
Part of ISSN: 1873-9946
Contributors: E Dreesen; R Faelens; G Van Assche; M Ferrante; S Vermeire; A Gils; T Bouillon
Source: Self-asserted source
Ruben Faelens via Crossref Metadata Search

Population pharmacokinetic modeling and simulations of dopamine Dd2 receptor occupancy of long-acting intramuscular risperidone-ISM

European Psychiatry
2016-03 | Journal article
Part of ISSN: 0924-9338
Contributors: J. Llaudó; L. Anta; I. Ayani; J. Martínez-González; I. Gutierro; R. Faelens; J. Winkler; E. Snoeck
Source: Self-asserted source
Ruben Faelens via Crossref Metadata Search

Spatiotemporal Imaging and Pharmacokinetic of Fluorescent Compounds in Zebrafish Eleuthero-Embryos After Different Routes of Administration

Other
Contributors: Marlly Guarin; Ruben Faelens; Arianna Giusti; Noémie De Croze; Marc Léonard; Deirdre Cabooter; Pieter Annaert; Peter de Witte; Annelii Ny
Source: Self-asserted source
Ruben Faelens via Crossref Metadata Search